[Fundamental mechanisms of amyloid fibril formation by alpha-synuclein in Parkinson's disease: quantitative modelling]

Med Sci (Paris). 2015 Jun-Jul;31(6-7):597-600. doi: 10.1051/medsci/20153106008. Epub 2015 Jul 7.

[Article in French]

Authors

Céline Galvagnion¹, Alexander K Buell¹

Affiliation

¹ Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, Royaume-Uni.

PMID: 26152159
DOI: 10.1051/medsci/20153106008

No abstract available

Publication types

News

MeSH terms

Amyloid / chemistry
Amyloid / metabolism*
Amyloid / pharmacokinetics
Humans
In Vitro Techniques
Lipids / pharmacology
Models, Molecular
Parkinson Disease / metabolism*
Parkinson Disease / pathology
Protein Aggregates / drug effects
Protein Aggregates / physiology
Protein Aggregation, Pathological / metabolism
alpha-Synuclein / chemistry
alpha-Synuclein / metabolism*
alpha-Synuclein / pharmacokinetics

Substances

Amyloid
Lipids
Protein Aggregates
alpha-Synuclein